Our guest this week is Antti Vuolanto, CEO of Herantis Pharma, and we discussed the science behind their approach, and the advantages and challenges of working in biotech in the Nordics. The post A Finnish biotech is making progress on Parkinson’s disease with support from The Michael J. Fox Foundation appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or ...
